- Home
- AQB vs SCNI Comparison
AQB vs SCNI Comparison
Compare AQB & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQB
- SCNI
- Stock Information
- Founded
- AQB 1991
- SCNI 2003
- Country
- AQB United States
- SCNI Israel
- Employees
- AQB 4
- SCNI N/A
- Industry
- AQB
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AQB
- SCNI Health Care
- Exchange
- AQB Nasdaq
- SCNI Nasdaq
- Market Cap
- AQB 4.0M
- SCNI 4.6M
- IPO Year
- AQB N/A
- SCNI N/A
- Fundamental
- Price
- AQB $1.05
- SCNI $1.07
- Analyst Decision
- AQB
- SCNI
- Analyst Count
- AQB 0
- SCNI 0
- Target Price
- AQB N/A
- SCNI N/A
- AVG Volume (30 Days)
- AQB 60.2K
- SCNI 79.8K
- Earning Date
- AQB 10-28-2025
- SCNI 11-24-2025
- Dividend Yield
- AQB N/A
- SCNI N/A
- EPS Growth
- AQB N/A
- SCNI N/A
- EPS
- AQB N/A
- SCNI 0.26
- Revenue
- AQB N/A
- SCNI $1,147,000.00
- Revenue This Year
- AQB N/A
- SCNI N/A
- Revenue Next Year
- AQB N/A
- SCNI N/A
- P/E Ratio
- AQB N/A
- SCNI $3.98
- Revenue Growth
- AQB N/A
- SCNI 303.87
- 52 Week Low
- AQB $0.47
- SCNI $1.00
- 52 Week High
- AQB $2.95
- SCNI $6.18
- Technical
- Relative Strength Index (RSI)
- AQB 36.43
- SCNI 36.96
- Support Level
- AQB $1.02
- SCNI $1.00
- Resistance Level
- AQB $1.13
- SCNI $1.55
- Average True Range (ATR)
- AQB 0.09
- SCNI 0.11
- MACD
- AQB -0.04
- SCNI -0.04
- Stochastic Oscillator
- AQB 18.18
- SCNI 19.99
About AQB AquaBounty Technologies Inc.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.